WO1996032090A1 - Dispersible particulate system for desensitizing teeth - Google Patents

Dispersible particulate system for desensitizing teeth Download PDF

Info

Publication number
WO1996032090A1
WO1996032090A1 PCT/US1996/004852 US9604852W WO9632090A1 WO 1996032090 A1 WO1996032090 A1 WO 1996032090A1 US 9604852 W US9604852 W US 9604852W WO 9632090 A1 WO9632090 A1 WO 9632090A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
clay
laponite
salt
salts
Prior art date
Application number
PCT/US1996/004852
Other languages
French (fr)
Inventor
Kenneth Markowitz
Mikhail Y. Gelfer
Original Assignee
Block Drug Company, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SK1376-97A priority Critical patent/SK137697A3/en
Priority to DK96910786T priority patent/DK0820270T3/en
Priority to JP8531103A priority patent/JPH11509518A/en
Priority to EP96910786A priority patent/EP0820270B1/en
Application filed by Block Drug Company, Inc. filed Critical Block Drug Company, Inc.
Priority to PL96322719A priority patent/PL184327B1/en
Priority to UA97115406A priority patent/UA48965C2/en
Priority to AU53885/96A priority patent/AU717149B2/en
Priority to AT96910786T priority patent/ATE242624T1/en
Priority to BR9604959A priority patent/BR9604959A/en
Priority to MX9707819A priority patent/MX9707819A/en
Priority to DE69628643T priority patent/DE69628643T2/en
Priority to NZ305772A priority patent/NZ305772A/en
Publication of WO1996032090A1 publication Critical patent/WO1996032090A1/en
Priority to BG101949A priority patent/BG101949A/en
Priority to HK98103056A priority patent/HK1004108A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Definitions

  • the invention is directed to new desensitizers for hypersensitive teeth and to methods of making and using such desensitizers.
  • Dentinal hypersensitivity causes pain in the mouth of a patient when a nerve in an affected tooth is exposed to certain external stimuli, including temperature and tactile stimuli.
  • One possible source of dental hypersensitivity is that the dentin of affected teeth is over-exposed to the stimuli due to injury, disease or some other reason.
  • Dentin generally contains channels, called tubules, that allow material and energy transport between the exterior of the dentin and the interior of the tooth where the nerve resides. Exposure of these tubules to external stimuli can cause irritation of the nerve in a tooth, leading to discomfort.
  • Dental hypersensitivity is generally treated by either treating the nerve in the tooth to make it less sensitive to stimuli or by blocking or occluding the tubules to prevent or limit exposure of the nerve to external stimuli and limit the stimulus triggered fluid movements in the dentinal tubules.
  • Treatments that directly affect the nerve generally interfere with the electrolyte balance near the nerve to affect the outer membranes of the nerve so that the nerve does not "fire” as frequently or as strongly as an untreated nerve.
  • Useful agents in treating dental hypersensitivity in this manner include potassium nitrate, as set forth in U.S. Patent No. 3,863,006 to Hodosh. issued January 28, 1975, potassium chloride, as set forth in U.S. Patent No. 4,751,072 to Ki m, issued June 14, 1988, potassium bicarbonate, as set forth in U.S. Patent No. 4,631,185 to Kim. issued December 23, 1986, and strontium chloride, as set forth in U.S. Patent No. 3,122,483 to
  • Occlusion of the tubules provides an alternative method of treatment.
  • Useful reported agents include polymeric agents such as Caibopol, as set forth in U.S. Patent No.
  • Apatite can also be an anti-hypereeniativity agent.
  • U.S. Patent No. 4,634,589 to Schfillsr issued January 6, 1987, and U.S. Patent No. 4,710,372, issued December 1, 1987, also to Scheller, disclose dentifrices for hypersensitive teeth containing apatite having an average particle size of less than 10 microns and optionally a local anesthetic. No other soluble mineral salts are permitted to exert any interfering effect in these patents. The apatite reduces the diameter of the dentin channels.
  • Montmorrolinite clay has also been reported as a desensitizing agent in U.S. Patent No. 4,992,258 to Mason, issued February 12, 1991.
  • mo ntmorrolinite clay is not compatible with most known fluoridating agents and thus has limited use.
  • montmorrolinite clay loses its ability to thicken a dentifrice and has reduced ability to block tubules in the presence of inorganic salts, such as potassium salts, so its use as a desensitizer is limited.
  • U.S. Patent No. 4,081,526 to Asakawa et al. discloses dentifrice compositions comprising 0.5 to 13% of a hectorite clay such as Laponite, for removing plaque from the teeth.
  • the principal object of the present invention therefore is to provide an effective tubule blocking agent that is compatible with fluorides and other conventional dentifrice ingredients and that is also organolepticaily acceptable.
  • the invention provides a desensitizing agent for hypersensitive teeth comprising a hectorite clay, such as Laponite clay.
  • a desensitizing agent for hypersensitive teeth comprising a hectorite clay, such as Laponite clay.
  • the invention further provides a method for treating hypersensitive teeth by contacting the teeth with a desensitizing formulation comprising a therapeutic amount of a hectorite clay, such as Laponite clay.
  • the invention comprises a composition for treating hypersensitive teeth, such as a dentifrice (either a paste or a gel) or other appropriate oral vehicle.
  • the composition comprises a hectorite clay in an amount and in a formulation sufficient to desensitize teeth.
  • Preferred hectorite clays include Laponite clays, and especially preferred are treated, so-called "synthetic" hectorite clays such as LAPONTTE D ® and LAPONITE DF ® , both sold by Southern Clay Products, Inc.
  • LAPONITE DF ® LAPONITE DF ®
  • Laponites are synthetic hectorite clays composed of magnesium, lithium, silica, oxygen, hydrogen, and sodium-
  • Laponites are composed in the dry state of platelets arranged in stacks. Each platelet has a double layer of tetrahedral silica bonded to oxygen atoms. Between the two silica layers there is a sheet of cations composed of magnesium and lithium in a 5.3 to 0.7 ratio. These cations coordinate the inner row of silica bound oxygens and OH groups.
  • the partial substitution of Magnesium (+2) with Lithium (+ 1) imparts an overall negative charge to the silica surface.
  • compositions in which Laponite clays are dispersed so as to prevent or hinder the formation of gel structure demonstrate superior performance in desensitizing capability, as measured by tubule blocking experiments. Such compositions typically use higher amounts of clay than found with compositions manifesting ideal gel structures.
  • inorganic dispersants and organic polymeric dispersants enhance the desensitizing performance of the Laponite clay. Laponite clay-containing compositions with such added dispersants have superior efficacy, demonstrate pleasant organoleptic characteristics, and are compatible with fluoride and most other dentifrice ingredients.
  • Fluoride treated Laponite clays are preferred for their ability to coexist with fluoride in a dentifrice.
  • Dentifrices and mixtures containing fluoride sources and hectorite clays or fluoride treated Laponite clays were examined for fluoride bioavailability, and dentifrices containing untreated hectorite clays reduced sodium fluoride availability, while fluoride treated Laponite clay dentifrices retained full fluoride bioavailability.
  • the dentifrice formulation is in the form of a paste or a gel that comprises from about 0.1% by weight to about 25% by wright of clay.
  • the clay comprises from about 1% clay to about 20% by weight of the clay, and, most preferably from about 2 % to about 15 %.
  • the clay may also be incorporated into other oral care formulations such as mouth rinses, as well as dentifrice formulations.
  • the flow reducing efficacy of the clay can surprisingly be improved by adding dispersants such as salts, thickeners, or other additives.
  • Preferred salts include: potassium salts, strontium salts (espedally preferred salts include desensitizing salts, such as potassium nitrate, potassium chloride, potassium bicarbonate and strontium chloride), and pyrophosphate salts, especially potassium and sodium tetrapyrophosphate salts and potassium and sodium add pyrophosphate salts.
  • Preferred thickeners include polymeric thickeners, and espedally preferred are cellulosic thickeners, including ionicaily modified cellulosic polymers such as sodium carboxymethyl cellulose, a product of Aqualon, and a cationically modified cellulosic polymer known as CELQUAT ® , a product of National Starch and Chemical Company.
  • CELQUAT ® a product of National Starch and Chemical Company.
  • hectorite clays espedally Laponite clays
  • Aspects of clay chemistry are discussed in more detail in the Mayes article mentioned above and in U.S. Patent
  • Oral rinses using the clay can be in the form of oral solutions or dispersions. Oral rinses may contain conventional flavors, colorants and other additives having organoleptic or therapeutic efficacy.
  • Dentifrices made using the hectorite clay will usually be water-based and will contain a humectant such as glycerin, sorbitol or other sugar alcohol, propylene glycol or polyethylene glycol. The dentifrice may be a paste or a gel.
  • the gelling agent may be an alkali metal carboxymethyl cellulose, hydroxy ethyl cellulose or hydroxy methyl cellulose, xanlhan gum, viscarin, iota carrageenan, gelatin, starch, glucose, sucrose, polyvinyl pyrollidone, polyvinyl alcohol, gum tragacanth, gum daraya, hydroxy propyl cellulose, methyl cellulose and sodium alginate, and magnesium aluminum silicate gel.
  • polishing agents such as precipitated silica, hydrated silica and other known abrasive polishing agents, fluoride, detergents, coloring or whitening agents such as titanium dioxide, fragrances and flavorings.
  • Additional therapeutic agents such as tartar control agents, antibasterial agents such as Triclosan or chlorhexadine, may also be added.
  • a dentifrice in accordance with the invention may be made by mixing the ingredients in any conventional manner, for example by creating a gel with the water and gelling agent and then adding the water soluble ingredients. Finally, a surfactant is added and the hydrophobic ingredients are then added. The mixture is then packaged in a convention dentifrice container such as a tube, and applied to the surface of the teeth through conventional brushing, coating, painting or other direct or indirect application technique.
  • a convention dentifrice container such as a tube
  • This spedal leak proof chamber is connected to a pressurized fluid reservoir containing a tissue culture fluid.
  • a pressurized fluid reservoir containing a tissue culture fluid.
  • the fluid can be maintained at physiological pH.
  • the disks are wetted with human saliva to approximate the intraoral condition.
  • the apparatus includes a glass capillary tube mounted on a ruler or other measuring instrument. An air bubble is injected into the glass capillary tube. By measuring the displacement of this bubble as a function of time the fluid flow through the dentin disk can be measured. (It has been reported that fluid actually flows out of dentin tubules from the interior of a normal human tooth.)
  • the experimental mixture or dentifrice is applied to the external disk surface with a nylon brush. After a defined period of brushing, the experimental material is rinsed off, and the post application hydraulic conductance is measured. In this fashion the ability of various experimental materials, both alone and as components of dentifrice systems, can be tested for the ability to obstruct fluid flow in the dentinai tubules. The percent flow reduction induced by brushing with experimental materials can then be calculated. Examples 1-5
  • Combinations of Laponite clays with water and other specified ingredients were prepared and tested for flow reduction using the method set forth above. Each combination had the composition set out in Table 1 and had the flow reduction shown in Table 1.
  • the examples show the good dentin fluid flow reducing ability of hectorite clays, espedally when the clay is associated with a dispersant, such as a polymeric dispersant or salts.
  • dentifrice formulations were prepared in the following manner.
  • a vacuum system such as whipmixer for the laboratory scale or Koruma mixer for larger (pilot plant) batches.
  • Key ingredients such as sodium fluoride (or sodium MFP), tetrapotassium pyrophosphate, trisodium phosphate, potassium or strontium salts, as appropriate, are added to the mixer, followed by sodium saccharin, silicon dioxide and LAPONITE DF.
  • the above bulk was mixed for approximately 10-30 minutes (under vacuum) followed by the addition of abrasives, gum premix (humectant and gums), flavor and detergents. Final mixing of 20-30 minutes was conducted under vacuum to dea ⁇ rate the product.

Abstract

A method for treating hypersensitive teeth by treating the teeth with an oral composition comprising hectorite clay, especially Laponite clay.

Description

DISPERSIBLE PARΗCULATE SYSTEM FOR DESENSITIZING TEETH
1. Field of the Invention
The invention is directed to new desensitizers for hypersensitive teeth and to methods of making and using such desensitizers. 2. Description of Related Art
Dentinal hypersensitivity causes pain in the mouth of a patient when a nerve in an affected tooth is exposed to certain external stimuli, including temperature and tactile stimuli. One possible source of dental hypersensitivity is that the dentin of affected teeth is over-exposed to the stimuli due to injury, disease or some other reason. Dentin generally contains channels, called tubules, that allow material and energy transport between the exterior of the dentin and the interior of the tooth where the nerve resides. Exposure of these tubules to external stimuli can cause irritation of the nerve in a tooth, leading to discomfort. Although the exact mechanism of hypersensitivity remains under investigation, recent investigations have shown that the pain triggered by air currents is related to the number of exposed tubules per unit area of dentin (Kontturi-Narhi, Dentin Hypersensitivity - Factors Related to the Occurrence of Pain Symptoms.
Kuopio University Publications B. Dental Sciences 5.) According to the hydrodynamic theory of dentin sensitivity mechanical and thermal stimuli of the exposed smear layer free dentin suifacd, induces minute movements of the intratubular fluid. These fluid movements induce pain encoding nerve responses in the intradental nerves located near the dentin/pulp border. Recent
investigations have strengthened the experimental evidence in support of this relationship (B. Matthews and N. Vongsavan Archs Oral Biol, 39 (Suppl): 875-955, 1994). Dental hypersensitivity is generally treated by either treating the nerve in the tooth to make it less sensitive to stimuli or by blocking or occluding the tubules to prevent or limit exposure of the nerve to external stimuli and limit the stimulus triggered fluid movements in the dentinal tubules.
Treatments that directly affect the nerve generally interfere with the electrolyte balance near the nerve to affect the outer membranes of the nerve so that the nerve does not "fire" as frequently or as strongly as an untreated nerve. Useful agents in treating dental hypersensitivity in this manner include potassium nitrate, as set forth in U.S. Patent No. 3,863,006 to Hodosh. issued January 28, 1975, potassium chloride, as set forth in U.S. Patent No. 4,751,072 to Ki m, issued June 14, 1988, potassium bicarbonate, as set forth in U.S. Patent No. 4,631,185 to Kim. issued December 23, 1986, and strontium chloride, as set forth in U.S. Patent No. 3,122,483 to
Rosenthal, issued February 25, 1964.
Occlusion of the tubules provides an alternative method of treatment. Useful reported agents include polymeric agents such as Caibopol, as set forth in U.S. Patent No.
5,270,031 to Lim et al., issued December 14, 1993, and certain polystyrene beads, as set forth in U.S. Patent No. 5,211,939 to Turesky et al., issued May 18, 1993.
Apatite can also be an anti-hypereeniativity agent. U.S. Patent No. 4,634,589 to Schfillsr, issued January 6, 1987, and U.S. Patent No. 4,710,372, issued December 1, 1987, also to Scheller, disclose dentifrices for hypersensitive teeth containing apatite having an average particle size of less than 10 microns and optionally a local anesthetic. No other soluble mineral salts are permitted to exert any interfering effect in these patents. The apatite reduces the diameter of the dentin channels.
Montmorrolinite clay has also been reported as a desensitizing agent in U.S. Patent No. 4,992,258 to Mason, issued February 12, 1991. Unfortunately, mo ntmorrolinite clay is not compatible with most known fluoridating agents and thus has limited use. In addition, montmorrolinite clay loses its ability to thicken a dentifrice and has reduced ability to block tubules in the presence of inorganic salts, such as potassium salts, so its use as a desensitizer is limited.
Other types of clays have been used in dental applications, although not in a desensitizing capacity. With the advent of clear gel dentifrices, hectorite clays, especially laponite clays, have been used as thickeners for dentifrices, for example as reported in U.S. Patent No. 4,069,310 to Harrison and in Mayes, B., "Synthetic Hectorite— A New Toothpaste Binder," International Journal of Cosmetic Science, 1, 329-340 (1979). While thickeners and binders are usually found in dentifrices at about 1% by weight, the Harrison patent indicates that the thick ener may be present in amounts up to 5% by weight Indeed, the Mason patent discussed above indicates that laponite may be one of a number of thicken ers used in the dentifrice, despite its teaching of montmorrolinite clay as a desensitizer..
U.S. Patent No. 4,474,750, Gaffar et al., issued October 2, 1984, discloses toothpaste, cream or gel in which the thickening agent can be Laponite CP or SP in an amount up to about 10% by weight. There is no disclosure in the patent that the Laponite is incorporated in an oral composition for the purpose of treating hypersensitive teeth.
U.S. Patent No. 4,081,526 to Asakawa et al., issued March 28, 1978, discloses dentifrice compositions comprising 0.5 to 13% of a hectorite clay such as Laponite, for removing plaque from the teeth.
Despite the ongoing work in the field of desensitizers, a strong and long-felt need remains in the art for an effective tubule blocking agent that is compatible with fluorides and other conventional dentifrice ingredients. This agent must work well yet not be distasteful to use. It must be stable for the typical shelf life of a dentifrice, and it should be affordable. SUMMARY OF THE INNENTTON
The principal object of the present invention therefore is to provide an effective tubule blocking agent that is compatible with fluorides and other conventional dentifrice ingredients and that is also organolepticaily acceptable.
Additional objects and advantages of the invention will be set forth in part in the description that follows, and in part will be obvious from this description, or may be learned by practice of the invention. The objects and advantages of the invention may be realized and attained by means of the instrumentalities and combinations particularly pointed out in the appended claims.
To achieve the foregoing objects and in accordance with the purpose of the invention, as embodied and broadly described herein, the invention provides a desensitizing agent for hypersensitive teeth comprising a hectorite clay, such as Laponite clay. To further achieve the foregoing objects and in accordance with the purpose of the invention, the invention further provides a method for treating hypersensitive teeth by contacting the teeth with a desensitizing formulation comprising a therapeutic amount of a hectorite clay, such as Laponite clay.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Reference will now be made in detail to the presently preferred embodiments of the invention. The invention comprises a composition for treating hypersensitive teeth, such as a dentifrice (either a paste or a gel) or other appropriate oral vehicle. The composition comprises a hectorite clay in an amount and in a formulation sufficient to desensitize teeth. Preferred hectorite clays include Laponite clays, and especially preferred are treated, so-called "synthetic" hectorite clays such as LAPONTTE D® and LAPONITE DF®, both sold by Southern Clay Products, Inc.
These clays have been treated to make them suitable for dental purposes (as thickeners for dear gel dentifrices), and LAPONITE DF® has been treated by the addition of fluorine to the clay to prevent absorption of fluoride from dentifrice formulations. Additional preferred Laponite clays, sold under the trade name LAPONITE®, are products of Laporte Industries Inc. Laponites are synthetic hectorite clays composed of magnesium, lithium, silica, oxygen, hydrogen, and sodium-
Like other clays, Laponites are composed in the dry state of platelets arranged in stacks. Each platelet has a double layer of tetrahedral silica bonded to oxygen atoms. Between the two silica layers there is a sheet of cations composed of magnesium and lithium in a 5.3 to 0.7 ratio. These cations coordinate the inner row of silica bound oxygens and OH groups. The partial substitution of Magnesium (+2) with Lithium (+ 1) imparts an overall negative charge to the silica surface.
The presence of incompletely complexed cations which are part of the center (Mg, Li) sheet impart a positive charge on the edges of the platelet.
In between individual stacked platelets are exchangeable cations such as sodium. When a Laponite clay is properly dispersed in water, these exchangeable cations draw water into the spaces between the platelets via osmotic forces. This bulk inflow of water forces the platdets apart. When Laponite clay is properly dispersed in water in the presence of low levels of electrolytes, the anionic silica faces and the cationic edges can electrostatically attract each other. This leads to the formation of what is known a s a card house structure. Shear stresses can readily disrupt this card house structure. This structure formation and disruption by shear stress means that Laponite clay dispersions have marked thixotropic properties that make them attractive as a thickening agents, espedally for clear gel dentifrices.
Importantly and unexpectedly, however, concentrations and chemical environmental conditions which favor structured gel formation with Laponite clay dispersions do not necessarily favor desensitizing efficacy. Compositions in which Laponite clays are dispersed so as to prevent or hinder the formation of gel structure demonstrate superior performance in desensitizing capability, as measured by tubule blocking experiments. Such compositions typically use higher amounts of clay than found with compositions manifesting ideal gel structures. In addition, inorganic dispersants and organic polymeric dispersants enhance the desensitizing performance of the Laponite clay. Laponite clay-containing compositions with such added dispersants have superior efficacy, demonstrate pleasant organoleptic characteristics, and are compatible with fluoride and most other dentifrice ingredients.
Fluoride treated Laponite clays are preferred for their ability to coexist with fluoride in a dentifrice. Dentifrices and mixtures containing fluoride sources and hectorite clays or fluoride treated Laponite clays were examined for fluoride bioavailability, and dentifrices containing untreated hectorite clays reduced sodium fluoride availability, while fluoride treated Laponite clay dentifrices retained full fluoride bioavailability. Preferably the dentifrice formulation is in the form of a paste or a gel that comprises from about 0.1% by weight to about 25% by wright of clay. More preferably, the clay comprises from about 1% clay to about 20% by weight of the clay, and, most preferably from about 2 % to about 15 %. The clay may also be incorporated into other oral care formulations such as mouth rinses, as well as dentifrice formulations.
The flow reducing efficacy of the clay can surprisingly be improved by adding dispersants such as salts, thickeners, or other additives. Preferred salts include: potassium salts, strontium salts (espedally preferred salts include desensitizing salts, such as potassium nitrate, potassium chloride, potassium bicarbonate and strontium chloride), and pyrophosphate salts, especially potassium and sodium tetrapyrophosphate salts and potassium and sodium add pyrophosphate salts. Preferred thickeners include polymeric thickeners, and espedally preferred are cellulosic thickeners, including ionicaily modified cellulosic polymers such as sodium carboxymethyl cellulose, a product of Aqualon, and a cationically modified cellulosic polymer known as CELQUAT®, a product of National Starch and Chemical Company. When tested by itself, the CELQUAT® polymer induced inconsistent dentin fluid flow reductions as measured using the technique set out in the examples. In contrast, when tested as part of a prototype dentifrice containing a hectorite clay, consistently high flow reductions were observed.
Although the inventors do not wish to be bound by any theory, it appears that hectorite clays, espedally Laponite clays, comprise a plurality of individual mineral platelets having positively charged edges and negatively charged fiat faces. It seems that the cationically charged modified cellulose and other positively charged entities can interact with the anionic face of the clay, resulting in better dispersion of the clay leading to a particle size appropriate for penetrating dentin tubules, and a modification of the electrochemical characteristics of the particle resulting in enhanced electrostatic adherence of the clay to the tubule wall. Aspects of clay chemistry are discussed in more detail in the Mayes article mentioned above and in U.S. Patent
No. 4,621,070 to Pinnayaia et al., issued November 4, 1986.
Oral rinses using the clay can be in the form of oral solutions or dispersions. Oral rinses may contain conventional flavors, colorants and other additives having organoleptic or therapeutic efficacy. Dentifrices made using the hectorite clay will usually be water-based and will contain a humectant such as glycerin, sorbitol or other sugar alcohol, propylene glycol or polyethylene glycol. The dentifrice may be a paste or a gel. The gelling agent may be an alkali metal carboxymethyl cellulose, hydroxy ethyl cellulose or hydroxy methyl cellulose, xanlhan gum, viscarin, iota carrageenan, gelatin, starch, glucose, sucrose, polyvinyl pyrollidone, polyvinyl alcohol, gum tragacanth, gum daraya, hydroxy propyl cellulose, methyl cellulose and sodium alginate, and magnesium aluminum silicate gel. Preferred are those agents that are compatible with fluoride.
Additional agents useful in a dentifrice are polishing agents such as precipitated silica, hydrated silica and other known abrasive polishing agents, fluoride, detergents, coloring or whitening agents such as titanium dioxide, fragrances and flavorings. Additional therapeutic agents, such as tartar control agents, antibasterial agents such as Triclosan or chlorhexadine, may also be added.
A dentifrice in accordance with the invention may be made by mixing the ingredients in any conventional manner, for example by creating a gel with the water and gelling agent and then adding the water soluble ingredients. Finally, a surfactant is added and the hydrophobic ingredients are then added. The mixture is then packaged in a convention dentifrice container such as a tube, and applied to the surface of the teeth through conventional brushing, coating, painting or other direct or indirect application technique. The benefits of the invention will be demonstrated in the following examples.
EXAMPLES
Test Procedures
Dispersions of hectorite clays in water with various ingredients and prototype dentifrices containing hectorite clays were tested using an in vitro model of dentin sensitivity first described by Pashley (J. Periodontology, Vol. 55, No. 9, p.522, Sept 1984). U.S. Patent
5,270,031 to Lim et al., issued December 14, 1993, also describes this methodology. In this method intact human molars free of caries or restorations are sectioned perpendicular to the long axis of the tooth with a metallurgical saw into thi n sections about 0.4 to 0.6 mm thick. Sections containing dentin and free of enamel are retained for testing. These sections are then etched with a EDTA (ethylenediamine tetra acetic acid) solution to remove the smear layer. The disc is mounted on a split chamber device as reported in J. Dent. Research,
57:187 (1978). This spedal leak proof chamber is connected to a pressurized fluid reservoir containing a tissue culture fluid. By using a mixture of pressurized N2 and CO2 gas, the fluid can be maintained at physiological pH. To further ensure accuracy, the disks are wetted with human saliva to approximate the intraoral condition. The apparatus includes a glass capillary tube mounted on a ruler or other measuring instrument. An air bubble is injected into the glass capillary tube. By measuring the displacement of this bubble as a function of time the fluid flow through the dentin disk can be measured. (It has been reported that fluid actually flows out of dentin tubules from the interior of a normal human tooth.)
Following measurement of the baseline fluid flow in the dentin disk, the experimental mixture or dentifrice is applied to the external disk surface with a nylon brush. After a defined period of brushing, the experimental material is rinsed off, and the post application hydraulic conductance is measured. In this fashion the ability of various experimental materials, both alone and as components of dentifrice systems, can be tested for the ability to obstruct fluid flow in the dentinai tubules. The percent flow reduction induced by brushing with experimental materials can then be calculated. Examples 1-5
Combinations of Laponite clays with water and other specified ingredients were prepared and tested for flow reduction using the method set forth above. Each combination had the composition set out in Table 1 and had the flow reduction shown in Table 1. The examples show the good dentin fluid flow reducing ability of hectorite clays, espedally when the clay is associated with a dispersant, such as a polymeric dispersant or salts.
Figure imgf000014_0001
Examples 6-13
The following dentifrice formulations were prepared in the following manner. Into a suitable mixer, equipped with a vacuum system, such as whipmixer for the laboratory scale or Koruma mixer for larger (pilot plant) batches, the required amount of purified water is added. Key ingredients such as sodium fluoride (or sodium MFP), tetrapotassium pyrophosphate, trisodium phosphate, potassium or strontium salts, as appropriate, are added to the mixer, followed by sodium saccharin, silicon dioxide and LAPONITE DF. The above bulk was mixed for approximately 10-30 minutes (under vacuum) followed by the addition of abrasives, gum premix (humectant and gums), flavor and detergents. Final mixing of 20-30 minutes was conducted under vacuum to deaεrate the product.
Figure imgf000015_0001
Figure imgf000016_0001
Figure imgf000017_0001
Figure imgf000018_0001
Figure imgf000019_0001
Several of the dentifrice formulations described above were tested for their ability to reduce dentin fluid flow. The results of this testing are set out in Table 2.
Figure imgf000019_0002
The purpose of the above description is to illustrate some embodiments of the present invention without implying a limitation. It will apparent to those skilled in the art that various modifications and variations may be made in the apparatus or procedure of the invention without departing from the scope or spirit of the invention.

Claims

CLAIMS: What is claimed is:
1. A composition for treating hypersensitive teeth comprising hectorite clay.
2. The composition of daim 1, wherein said clay is Laponite clay.
3. The composition of claim 2, wherein said clay contains fluoride.
4. The composition of claim 1, further comprising a dispersant.
5. The composition of claim 4, wherein said dispersant is a salt.
6. The composition of claim 5, wherein said ionic salt is an alkali salt
7. The composition of claim 5, wherein said salt is selected from the group consisting of alkali salts of pyrophosphates, nitrates, haϋdes, dtrates, carbonates, bicarbonates, and strontium salts and mixtures thereof
8. The composition of claim 4, wherein said dispersant is a cellulosic compound.
9. The composition of claim 8, wherein said cellulosic compound is cationically modified.
10. The composition of daim 9, wherein said cellulosic compound comprises a cationically modified cellulose..
11. The composition of claim 10, further comprising a salt
12. The composition of claim 11, wherein said salt is an alkali salt 13. The composition of claim 12, wherein said salt is selected from the group consisting of alkalai salts of pyrophosphates, nitrates, halides, dtrates, carbonates, bicarbonates, and strontium salts and mixtures thereof.
14. A method for treating a hypersensitive tooth, comprising administering to said tooth a therapeutically effective amount of the composition of claim 1. 15. A method for treating a hypersensitive tooth, comprising administering to said tooth a therapeutically effective amount of the composition of claim 4.
16. The use of hectorite clay as a desensitizing agent.
17. The use of Laponite clay as a desensitizing agent
18. The use of Laponite clay in combination with a dispersant as a desensitizing agent.
9. The use of Laponite clay modified for dental purposes as a desensitizing agent.
PCT/US1996/004852 1995-04-11 1996-04-10 Dispersible particulate system for desensitizing teeth WO1996032090A1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
UA97115406A UA48965C2 (en) 1995-04-11 1996-04-10 Composition and method for treating hypersensitive teeth, method for sealing the dentine canals
JP8531103A JPH11509518A (en) 1995-04-11 1996-04-10 Dispersible particulate system to eliminate tooth sensitivity
EP96910786A EP0820270B1 (en) 1995-04-11 1996-04-10 Dispersible particulate system for desensitizing teeth
AT96910786T ATE242624T1 (en) 1995-04-11 1996-04-10 SYSTEM OF DISPERSABLE PARTICLES FOR DESENSITIZING TEETH
PL96322719A PL184327B1 (en) 1995-04-11 1996-04-10 Disperse molecular system for desensitisation of teeth
DK96910786T DK0820270T3 (en) 1995-04-11 1996-04-10 Dispersible particulate system for teeth desensitization
AU53885/96A AU717149B2 (en) 1995-04-11 1996-04-10 Dispersible particulate system for desensitizing teeth
SK1376-97A SK137697A3 (en) 1995-04-11 1996-04-10 Dispersible particulate system for desensitizing teeth
BR9604959A BR9604959A (en) 1995-04-11 1996-04-10 Composition and method for the treatment of tooth desensitization
MX9707819A MX9707819A (en) 1996-04-10 1996-04-10 Dispersible particulate system for desensitizing teeth.
DE69628643T DE69628643T2 (en) 1995-04-11 1996-04-10 SYSTEM DISPERSIBLE PARTICLES FOR DESENSITIZING THE TEETH
NZ305772A NZ305772A (en) 1995-04-11 1996-04-10 Use of hectorite clay as filler for sensitive teeth
BG101949A BG101949A (en) 1995-04-11 1997-10-08 Dispersible particulate system for desensitizing teeth
HK98103056A HK1004108A1 (en) 1995-04-11 1998-04-14 Dispersible particulate system for desensitizing teeth

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/419,816 1995-04-11
US08/419,816 US5589159A (en) 1995-04-11 1995-04-11 Dispersible particulate system for desensitizing teeth

Publications (1)

Publication Number Publication Date
WO1996032090A1 true WO1996032090A1 (en) 1996-10-17

Family

ID=23663881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/004852 WO1996032090A1 (en) 1995-04-11 1996-04-10 Dispersible particulate system for desensitizing teeth

Country Status (24)

Country Link
US (1) US5589159A (en)
EP (1) EP0820270B1 (en)
JP (1) JPH11509518A (en)
KR (1) KR19980703780A (en)
CN (1) CN1102379C (en)
AR (1) AR004171A1 (en)
AT (1) ATE242624T1 (en)
AU (1) AU717149B2 (en)
BG (1) BG101949A (en)
BR (1) BR9604959A (en)
CA (1) CA2217861A1 (en)
CZ (1) CZ288829B6 (en)
DE (1) DE69628643T2 (en)
DK (1) DK0820270T3 (en)
ES (1) ES2201180T3 (en)
HK (1) HK1004108A1 (en)
HU (1) HUP9801702A3 (en)
NZ (1) NZ305772A (en)
PL (1) PL184327B1 (en)
PT (1) PT820270E (en)
RU (1) RU2163798C2 (en)
SK (1) SK137697A3 (en)
UA (1) UA48965C2 (en)
WO (1) WO1996032090A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094153A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
WO2015094154A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and a clay
US9554975B2 (en) 2005-03-21 2017-01-31 Glaxo Group Limited Alkyl sulfate free and orthophosphate free dentifrice composition comprising fluoride source and a silica dental abrasive
WO2021078685A1 (en) 2019-10-23 2021-04-29 Unilever Ip Holdings B.V. Method of reducing dental hypersensitivity

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885551A (en) * 1997-08-01 1999-03-23 Smetana; Alfred J. Treatment for dentinal hypersensitivity
US6241972B1 (en) * 1999-02-19 2001-06-05 Block Drug Company, Inc. Oral care formulation for the treatment of sensitivity teeth
AU2080700A (en) 1999-03-12 2000-09-14 Pfizer Products Inc. Compositions comprising a potassium salt active ingredient, including oral compositions for reducing dental nerve and dentin sensitivity comprising a non-menthol flavoring
EP1731132B1 (en) 2000-10-13 2008-12-10 Block Drug Company, Inc. Dental compositions for hypersensitive teeth
US6447756B1 (en) * 2000-11-08 2002-09-10 Colgate Palmolive Company Desensitizing dual component dentifrice
US6416745B1 (en) 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
JP2008505113A (en) * 2004-07-02 2008-02-21 ディスカス デンタル インプレッションズ インコーポレーテッド Dental composition having sensitivity reducing effect
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
US20080268001A1 (en) * 2007-04-30 2008-10-30 Lynette Zaidel Oral care composition to reduce or eliminate dental sensitivity
RU2543656C2 (en) * 2008-02-08 2015-03-10 Колгейт-Палмолив Компани Oral care product and method of using and making it
US20100047742A1 (en) * 2008-08-25 2010-02-25 Pitcock Jr William Henry Tubule-blocking silica materials for dentifrices
AR076178A1 (en) 2009-04-01 2011-05-26 Colgate Palmolive Co DOUBLE ACTION DENTIFRIC COMPOSITIONS TO PREVENT HYPERSENSITIVITY AND PROMOTE REMINERALIZATION
US20110206749A1 (en) * 2010-02-19 2011-08-25 J.M. Huber Corporation Silica materials for reducing oral malador
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
US20110236444A1 (en) * 2010-03-25 2011-09-29 Darsillo Michael S Antimicrobial Silica Composites
RU2535088C2 (en) 2010-06-23 2014-12-10 Колгейт-Палмолив Компани Therapeutic oral compositions
JP5841608B2 (en) 2010-11-12 2016-01-13 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company Oral care products and methods of use and manufacture thereof
CN107432832A (en) 2010-11-12 2017-12-05 高露洁-棕榄公司 Oral care product and its use and preparation method
US9717929B2 (en) * 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
US20130251772A1 (en) * 2010-12-07 2013-09-26 Colgate-Palmolive Company Dentifrice Compositions Containing Calcium Silicate
JP5720416B2 (en) * 2011-05-19 2015-05-20 ライオン株式会社 Gel oral composition and method for producing the same
AU2011383635B2 (en) * 2011-12-21 2014-10-23 Colgate-Palmolive Company Oral care compositions
CN115315293A (en) 2020-03-27 2022-11-08 高露洁-棕榄公司 Oral care compositions and methods of use
US11931443B2 (en) 2020-03-27 2024-03-19 Colgate-Palmolive Company Oral care compositions and methods of use
CA3231150A1 (en) 2021-09-23 2023-03-30 Carlo DAEP Oral care compositions and methods of use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992258A (en) * 1989-10-23 1991-02-12 Colgate-Palmolive Company Dentrifice composition
US5211939A (en) * 1991-09-13 1993-05-18 Gillette Canada Method for desensitizing teeth
US5240697A (en) * 1991-10-17 1993-08-31 Colgate-Palmolive Company Desensitizing anti-tartar dentifrice
US5250288A (en) * 1991-09-13 1993-10-05 Gillette Canada, Inc. Method for desensitizing teeth
US5270031A (en) * 1991-12-20 1993-12-14 Block Drug Company Inc. Dentinal desensitizing compositions
US5328682A (en) * 1990-10-25 1994-07-12 Boots Company Plc Mouthwash
US5374417A (en) * 1991-10-17 1994-12-20 Colgate Palmolive Company Desensitizing dentifrice

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418053A (en) * 1980-03-17 1983-11-29 Indiana University Foundation Dental prophylaxis compositions and their use
JPH0742219B2 (en) * 1984-07-26 1995-05-10 ライオン株式会社 Oral composition
GB9115153D0 (en) * 1991-07-12 1991-08-28 Patel Bipin C M Sol-gel composition for producing glassy coatings
GB9115154D0 (en) * 1991-07-12 1991-08-28 Patel Bipin C M Sol-gel composition for producing glassy coatings

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992258A (en) * 1989-10-23 1991-02-12 Colgate-Palmolive Company Dentrifice composition
US5328682A (en) * 1990-10-25 1994-07-12 Boots Company Plc Mouthwash
US5211939A (en) * 1991-09-13 1993-05-18 Gillette Canada Method for desensitizing teeth
US5250288A (en) * 1991-09-13 1993-10-05 Gillette Canada, Inc. Method for desensitizing teeth
US5240697A (en) * 1991-10-17 1993-08-31 Colgate-Palmolive Company Desensitizing anti-tartar dentifrice
US5352439A (en) * 1991-10-17 1994-10-04 Colgate Palmolive Company Desensitizing anti-tartar dentifrice
US5374417A (en) * 1991-10-17 1994-12-20 Colgate Palmolive Company Desensitizing dentifrice
US5270031A (en) * 1991-12-20 1993-12-14 Block Drug Company Inc. Dentinal desensitizing compositions

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9554975B2 (en) 2005-03-21 2017-01-31 Glaxo Group Limited Alkyl sulfate free and orthophosphate free dentifrice composition comprising fluoride source and a silica dental abrasive
WO2015094153A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
WO2015094154A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and a clay
AU2013408426B2 (en) * 2013-12-16 2017-02-02 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
AU2013408427B2 (en) * 2013-12-16 2017-02-02 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and a clay
US9949907B2 (en) 2013-12-16 2018-04-24 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and a clay
WO2021078685A1 (en) 2019-10-23 2021-04-29 Unilever Ip Holdings B.V. Method of reducing dental hypersensitivity

Also Published As

Publication number Publication date
HUP9801702A2 (en) 1998-11-30
EP0820270B1 (en) 2003-06-11
ES2201180T3 (en) 2004-03-16
AU5388596A (en) 1996-10-30
KR19980703780A (en) 1998-12-05
CN1186426A (en) 1998-07-01
CA2217861A1 (en) 1996-10-17
UA48965C2 (en) 2002-09-16
CZ288829B6 (en) 2001-09-12
PL322719A1 (en) 1998-02-16
AR004171A1 (en) 1998-11-04
DK0820270T3 (en) 2003-09-29
PT820270E (en) 2003-10-31
HUP9801702A3 (en) 1998-12-28
BR9604959A (en) 1998-07-14
DE69628643T2 (en) 2004-04-29
NZ305772A (en) 1999-02-25
RU2163798C2 (en) 2001-03-10
AU717149B2 (en) 2000-03-16
DE69628643D1 (en) 2003-07-17
EP0820270A1 (en) 1998-01-28
CZ321097A3 (en) 1998-03-18
EP0820270A4 (en) 1999-06-23
BG101949A (en) 1998-05-29
CN1102379C (en) 2003-03-05
PL184327B1 (en) 2002-10-31
JPH11509518A (en) 1999-08-24
HK1004108A1 (en) 1998-11-20
SK137697A3 (en) 1998-05-06
ATE242624T1 (en) 2003-06-15
US5589159A (en) 1996-12-31

Similar Documents

Publication Publication Date Title
EP0820270B1 (en) Dispersible particulate system for desensitizing teeth
EP1202705B1 (en) Composition for treating dentin hypersensitivity
EP1390004B1 (en) Dental composition for treating hypersensitive teeth
CA2420154A1 (en) Dental composition for hypersensitive teeth
JPH1017445A (en) Composition for oral cavity and its production
CA2192315A1 (en) Relief of dentinal hypersensitivity by submicron particles
US20070059257A1 (en) Dentinal composition for hypersensitive teeth
EP0102200B1 (en) Neutral topical sodium fluoride gel
EP2882499B1 (en) Methods and compositions for treating tooth hypersensitivity
US5885551A (en) Treatment for dentinal hypersensitivity
WO2014023465A1 (en) Methods and compositions for treating tooth hypersensitivity
MXPA97007819A (en) System in dispersible particles to insensibilize dien
US8951506B2 (en) Formulation and method for treatment of teeth
JP2002068948A (en) Composition for oral cavity and chewing composition
JP2000095655A (en) Oral cavity composition
JPH04275213A (en) Agent for oral cavity

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96194361.0

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AU BG BR CA CN CZ HU JP KR MX NZ PL RO RU SG SK UA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996910786

Country of ref document: EP

Ref document number: 97-01847

Country of ref document: RO

ENP Entry into the national phase

Ref document number: 2217861

Country of ref document: CA

Ref document number: 2217861

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1019970707180

Country of ref document: KR

Ref document number: 305772

Country of ref document: NZ

Ref document number: PA/a/1997/007819

Country of ref document: MX

Ref document number: 137697

Country of ref document: SK

Ref document number: PV1997-3210

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 1996 531103

Country of ref document: JP

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1996910786

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1997-3210

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019970707180

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: PV1997-3210

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1996910786

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1019970707180

Country of ref document: KR